At Almac, GMP regulations set by the Pharmaceutical regulatory bodies such as the FDA (Food and Drug Administration) and the MHRA (Medicine and Healthcare products Regulatory Authority) ensure that manufacturing processes and facilities are properly designed, monitored and controlled. The GMP environment guarantees the identity, strength, quality and purity of drug products. In this webinar, technical leader at Almac, Kerry Hughes, will discuss the application of NMR in the GMP setting to ensure continued high-quality performance of drug discovery, drug development and manufacturing workflows. The organization has two Bruker instruments for the whole spectrum of GMP activities, from the early phase of development through to the final commercial product, which could be anything from raw materials through to active pharmaceutical ingredients that are ready for release.
The webinar will provide an overview of GMP and the convenience of applying NMR to the molecules the company is developing and using. NMR requires few set-up stages and the instruments are also open access, walk-up devices. Specific examples will be given of how NMR is applied to meet GMP regulations.
This webinar will appeal to people working in drug development, manufacture, quality control and quality assurance. It will also be of interest to those in non-pharmaceutical industries such as smaller businesses or universities who are looking to conform with GMP regulations.
Dr. Kerry Hughes
Team Leader at Almac in Craigavon
Dr. Sukhvinder Chohan
European Business Development Manager - Biopharm & Pharma